Organicell Regenerative Medicine, Inc. (OTCMKTS:BPSR – Get Free Report) shares crossed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $2.29 and traded as high as $2.70. Organicell Regenerative Medicine shares last traded at $2.6380, with a volume of 2,787 shares trading hands.
Organicell Regenerative Medicine Stock Up 1.9%
The stock has a 50 day moving average price of $2.29 and a 200-day moving average price of $1.92.
About Organicell Regenerative Medicine
Organicell Regenerative Medicine, Inc is a clinical?stage biotechnology company dedicated to the development and commercialization of cell and exosome?based therapeutics for a variety of inflammatory and degenerative medical conditions. Leveraging its proprietary placental and amniotic tissue–derived platform, the company isolates and purifies extracellular vesicles (EVs) and mesenchymal?like cells, which are studied for their ability to modulate immune response and promote tissue repair. With an emphasis on regenerative medicine, Organicell’s research efforts aim to translate novel biologics into scalable treatments.
The company’s pipeline is anchored by exosome?centered product candidates that target pulmonary, ophthalmic, and musculoskeletal indications.
Featured Stories
- Five stocks we like better than Organicell Regenerative Medicine
- How a Family Trust May Be Able To Help Preserve Your Wealth
- Do not delete, read immediately
- Your Signature Is Missing – Act Before It’s Too Late
- The $100 Trillion AI Story No One Is Telling You
- NEW LAW: Congress Approves Setup For Digital Dollar?
Receive News & Ratings for Organicell Regenerative Medicine Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Organicell Regenerative Medicine and related companies with MarketBeat.com's FREE daily email newsletter.
